This article is rated B-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Aflibercept.
|
So there's details on a date of approval ofr use in DM/DMO, but not where. UK spelling of "oedema" so that suggests the EMA gave the thumbs up and the EC approved it -- but it could instead be the FDA's approval and date. Sucks not to be in the US or Europe though -- those places are irrelevant when it comes to this, it seems. — Preceding unsigned comment added by 213.107.159.3 ( talk) 21:14, 27 August 2015 (UTC)
Aflibercept (Zaltrap) is so expensive that, at the urging of Peter Bach, Memorial-Sloan Kettering decided not to use it.
http://nymag.com/news/features/cancer-drugs-2013-10/ The Cost of Living New drugs could extend cancer patients’ lives—by days. At a cost of thousands and thousands of dollars. Prompting some doctors to refuse to use them. By Stephen S. Hall New York Magazine Oct 20, 2013 -- Nbauman ( talk) 16:45, 21 October 2013 (UTC)
"In 2017, injections of aflibercept (HCPCS code J0178) were responsible for the most billing to Medicare Part B, at $2.36 billion." How much was used for cancer treatment, and how much was used for eye treatment? Thanks. ThomasYehYeh ( talk) 02:37, 30 December 2023 (UTC)
This article is rated B-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Aflibercept.
|
So there's details on a date of approval ofr use in DM/DMO, but not where. UK spelling of "oedema" so that suggests the EMA gave the thumbs up and the EC approved it -- but it could instead be the FDA's approval and date. Sucks not to be in the US or Europe though -- those places are irrelevant when it comes to this, it seems. — Preceding unsigned comment added by 213.107.159.3 ( talk) 21:14, 27 August 2015 (UTC)
Aflibercept (Zaltrap) is so expensive that, at the urging of Peter Bach, Memorial-Sloan Kettering decided not to use it.
http://nymag.com/news/features/cancer-drugs-2013-10/ The Cost of Living New drugs could extend cancer patients’ lives—by days. At a cost of thousands and thousands of dollars. Prompting some doctors to refuse to use them. By Stephen S. Hall New York Magazine Oct 20, 2013 -- Nbauman ( talk) 16:45, 21 October 2013 (UTC)
"In 2017, injections of aflibercept (HCPCS code J0178) were responsible for the most billing to Medicare Part B, at $2.36 billion." How much was used for cancer treatment, and how much was used for eye treatment? Thanks. ThomasYehYeh ( talk) 02:37, 30 December 2023 (UTC)